Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/cancerimmunol.3.046
Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment
Aurore Dumond1, Gilles Pagès1,2,*
- 1Scientific Centre of Monaco, Biomedical Department, 8 quai Antoine 1er, MC-98000 Monaco, Principality of Monaco
- 2University Cote D’Azur (UCA), Institute for research on cancer and aging of nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France
Corresponding Author
Gilles Pagès, Gilles.Pages@unice.fr
Received Date: March 31, 2021
Accepted Date: April 30, 2021
Citation:
Dumond A, Pagès G. Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment. J Cancer Immunol. 2021; 3(2): 111-114.
Copyright: © 2021 Dumond A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.